Triple
T21206807
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | John Stuelpnagel |
E522606
|
entity |
| Predicate | positionHeld |
P8
|
FINISHED |
| Object |
Executive Vice President of Illumina
Executive Vice President of Illumina is a senior leadership role at the genomics company Illumina, overseeing high-level corporate strategy and operations in the development of DNA sequencing and genetic analysis technologies.
|
E1472097
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Executive Vice President of Illumina | Statement: [John Stuelpnagel, positionHeld, Executive Vice President of Illumina]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Executive Vice President of Illumina Context triple: [John Stuelpnagel, positionHeld, Executive Vice President of Illumina]
-
A.
Chief Executive Officer of Altos Labs
The Chief Executive Officer of Altos Labs is the top executive leading the biotechnology company’s strategy and operations in its mission to develop therapies that reverse disease and potentially extend human healthspan.
-
B.
Chief Executive Officer of AstraZeneca
The Chief Executive Officer of AstraZeneca is the top executive responsible for leading the global biopharmaceutical company’s overall strategy, operations, and corporate direction.
-
C.
President of Palantir Technologies
The President of Palantir Technologies is a senior executive leader at the data analytics and software company known for its work with government and commercial clients on large-scale information integration and analysis.
-
D.
Chief Financial Officer of Hewlett-Packard
The Chief Financial Officer of Hewlett-Packard is the senior executive responsible for overseeing the company’s financial strategy, planning, reporting, and risk management.
-
E.
Chief Executive Officer of Tableau Software
The Chief Executive Officer of Tableau Software is the top executive responsible for leading the data visualization company’s overall strategy, operations, and growth.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Executive Vice President of Illumina Triple: [John Stuelpnagel, positionHeld, Executive Vice President of Illumina]
Generated description
Executive Vice President of Illumina is a senior leadership role at the genomics company Illumina, overseeing high-level corporate strategy and operations in the development of DNA sequencing and genetic analysis technologies.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Executive Vice President of Illumina Target entity description: Executive Vice President of Illumina is a senior leadership role at the genomics company Illumina, overseeing high-level corporate strategy and operations in the development of DNA sequencing and genetic analysis technologies.
-
A.
Chief Executive Officer of Altos Labs
The Chief Executive Officer of Altos Labs is the top executive leading the biotechnology company’s strategy and operations in its mission to develop therapies that reverse disease and potentially extend human healthspan.
-
B.
Chief Executive Officer of AstraZeneca
The Chief Executive Officer of AstraZeneca is the top executive responsible for leading the global biopharmaceutical company’s overall strategy, operations, and corporate direction.
-
C.
President of Palantir Technologies
The President of Palantir Technologies is a senior executive leader at the data analytics and software company known for its work with government and commercial clients on large-scale information integration and analysis.
-
D.
Chief Financial Officer of Hewlett-Packard
The Chief Financial Officer of Hewlett-Packard is the senior executive responsible for overseeing the company’s financial strategy, planning, reporting, and risk management.
-
E.
Chief Executive Officer of Tableau Software
The Chief Executive Officer of Tableau Software is the top executive responsible for leading the data visualization company’s overall strategy, operations, and growth.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b5112d8881909510b2dcdc93106d |
completed | April 16, 2026, 10:08 a.m. |
| NER | Named-entity recognition | batch_69e73435322c8190bf4156fbd14edc5c |
completed | April 21, 2026, 8:24 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a097ed2c0b48190bcaf2937004abbfd |
completed | May 17, 2026, 8:39 a.m. |
| NEDg | Description generation | batch_6a0980329bb4819088da49aec70f27a0 |
completed | May 17, 2026, 8:45 a.m. |
| NED2 | Entity disambiguation (via description) | batch_6a0981b76b108190a0c9ae60c81bd4fc |
completed | May 17, 2026, 8:52 a.m. |
Created at: April 16, 2026, 3:24 p.m.